The EU Commission opens investigation against two pharmaceutical companies on account of patent settlement agreement (Cephalon / Teva)

On 28 April 2011, the European Commission opened of its own motion formal competition proceedings against Cephalon, Inc. (“Cephalon”) and Teva

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Peter L'Ecluse, The EU Commission opens investigation against two pharmaceutical companies on account of patent settlement agreement (Cephalon / Teva), 28 April 2011, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 41138

Visites 292

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues